Litcius/Paper detail

Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole

James J. DiNicolantonio, Jorge Barroso-Aranda

2020Medical Hypotheses33 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAdenosinePentoxifyllinePharmacologyDipyridamoleAdenosine A2A receptorInflammationAntithromboticPlatelet activationHydroxychloroquineAdenosine receptorPlateletImmunologyReceptorInternal medicineAgonistDiseaseCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)Adenosine and Purinergic SignalingCOVID-19 Clinical Research StudiesPharmacological Receptor Mechanisms and Effects
Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole | Litcius